So... How do you choose which WEB site to contact????? How do you know who is an uninformed marketer versus who is the "real deal"???? Suggestion: You read further...
Following the FDA's imposition of a "Black Box" (maximum strength) Warning for Reglan in Feb 2009 (use longer than three (3) months strongly discouraged due to high risk of Tardive Dyskinesia - see February 26, 2009 FDA news bulletin reproduced here) Reglan and Tardive Dyskinesia websites proliferated. NOW, everyone purports to know Tardive Dyskinesia- even if they can't pronounce it...
McGlynn, Glisson & Mouton (Pharmaceutical team headed by Daniel J. McGlynn - pictured) has been a pioneer of Tardive Dyskinesia litigation and has handled Tardive Dyskinesia (TD) cases across the country since 1995. (See Accardo vs Cenac , 722 So 2d 302, La 1st Circuit Court of Appeals, 1998 - $2.3 million verdict for TD caused by Prolixin.) Since then, the firm has reviewed, handled, settled and/or prosecuted hundreds of TD cases - whether caused by antipsychotics, by Reglan (generic name Metoclopramide) or by other dopamine blocking medications. Even before the FDA's black box warning for Reglan, McGlynn, Glisson & Mouton had long since been representing individuals suffering from Tardive Dyskinesia caused by Reglan (or generic Metoclopramide). Prior to the FDA's black box action, McGlynn Glisson & Mouton had already initiated (and in some instances completed) more than 50 claims versus the various manufacturers of Reglan/Metoclopramide and/or the doctors that prescribed it. While the marketers and/or other law firms are still learning the vocabulary, we are geared up and ready to try Reglan/Tardive Dyskinesia cases across the Country. No other firm or person in the USA can compare. This is what we do - Tardive Dyskinesia - especially if caused by Reglan. ( See sample list of TD jury verdicts. Settlements are generally confidential and cannot be disclosed.)
If you want to hire the firm that can "walk the walk and talk the talk", you need go no further. Please review our website and contact us today. You will get answers directly from the people who know and understand Tardive Dyskinesia. We are ready to evaluate and, if you qualify, prosecute your case immediately to the fullest extent and result possible.
Please contact our Firm immediately and directly (chances are you may well end up with us indirectly - if/when placed through a website or television marketer.)
UPDATE 1-US FDA: Stomach drugs need movement disorder warning
FDA Metoclopramide Warning
FDA slaps warning on heartburn drug tied to spasms
Important Note: If you are still taking Reglan (or other medication linked to Tardive Dyskinesia - see attached list) and are experiencing one or more of the possible symptoms (see attached list), please consult your physician immediately. If symptoms are severe, you may want to request referral to a neurologist, and, if available in your area, to a specialized MOVEMENT DISORDER NEUROLOGIST, regarding this difficult to diagnose, medication caused disease.
DO NOT DISCONTINUE use of Reglan without consulting a Physician.
Important Note: Given the delays and difficulties involved with the development of TD and/or the obtainment of a diagnosis of TD and the differences and subtleties of the time limits for filing suit versus manufacturers and/or physicians in the various States and US Territories, it is imperative that you seek legal advice promptly. While McGlynn Glisson & Mouton has the ability to promptly and thoroughly evaluate these issues, we cannot guarantee proper evaluation and timely filing of your claim if only minimal time remains for filing a claim within the applicable Statute of Limitations remains. Please call immediately for a free evaulation.
Toll Free:1-800-725-3555
or email us at:
TD@mcglynnglisson.com.
Back to Practice Areas